Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2022 Dec 19;16(12):e0010697. doi: 10.1371/journal.pntd.0010697

Prevalence of skin Neglected Tropical Diseases and superficial fungal infections in two peri-urban schools and one rural community setting in Togo

Bayaki Saka 1, Panawé Kassang 1, Piham Gnossike 1, Michael G Head 2,*, Abla Séfako Akakpo 1, Julienne Noude Teclessou 1, Yvette Moise Elegbede 3, Abas Mouhari-Toure 4, Garba Mahamadou 1, Kokoé Tevi 1, Kafouyema Katsou 1, Koussake Kombaté 1, Stephen L Walker 5, Palokinam Pitché 1
Editor: Paul J Converse6
PMCID: PMC9810153  PMID: 36534701

Abstract

Introduction

Skin neglected tropical diseases (NTDs), are endemic and under-diagnosed in many lower-income communities. The objective of this study was to determine the prevalence of skin NTDs and fungal infections in two primary schools and a community setting in rural Togo.

Method

This was a cross-sectional study that took place between June-October 2021. The two primary schools are located on the outskirts of Lomé, the capital city. The community setting was Ndjéi, in north-east Togo. Study sites were purposively selected. Dermatologists examined the skin of study participants. Diagnosis of skin NTDs were made clinically.

Results

A total of 1401 individuals were examined, 954 (68.1%) from Ndjéi community, and 447 (31.9%) were children in the schools. Cutaneous skin infections were diagnosed in 438 (31.3%) participants, of whom 355 (81%) were in community settings. There were 105 observed skin NTDs (7.5%). Within the school setting, there were 20 individuals with NTDs (4.5% of 447 participants), and 85 NTDs (8.9%) from 954 community participants. Across all settings 68/1020 (6.7%) NTDs were in children, and 37/381 (9.7%) in adults. In addition, there were 333 observed mycoses (23.8% prevalence). The main cutaneous NTDs diagnosed were scabies (n = 86; 6.1%) and suspected yaws (n = 16, 1.1%). The prevalence of scabies in schools was 4.3%, and 7.0% in the rural community. One case of leprosy was diagnosed in each school and the rural community, and one suspected Buruli Ulcer case in the community. In the school setting, five (6%) children with a skin NTD reported being stigmatised, four of whom had refused to attend school because of their dermatosis. In Ndjéi, 44 (4.6%) individuals reported having experienced stigma and 41 (93.2%) of them missed at least one day of school or work.

Conclusion

This study shows that the burden of scabies and skin infections such as superficial mycoses is high in the school and rural community settings in Togo, with associated presence of stigma. Improved health promotion and education across institutional and community settings may reduce stigma and encourage early reporting of skin infection cases to a health facility.

Author summary

This article is a group of conditions called skin Neglected Tropical Diseases (NTDs). The study takes place in Togo, West Africa. There is very little evidence around how widespread NTDs are in Togo. Local dermatologists carried out skin examinations of students in two schools on the edge of Lomé, the capital city. They also examined skin of community residents in rural Togo, in the north-east of the country. We show how the prevalence of fungal skin disease is very high, and also diagnosed numerous cases of scabies (one of the skin NTDs). Cases of leprosy and Buruli Ulcer were also found. Additionally, there were high levels of reported stigma. Our findings show how addressing this burden of disease is vital to improve individual and population health, but also to reduce the socio-economic consequences of these treatable conditions.

Introduction

Skin Neglected tropical diseases (NTDs) are a group of diseases that are particularly prevalent in many low and middle income countries. According to the World Health Organization (WHO), more than one billion people, mainly in lower-income settings, are affected by one or more of these diseases [1]. Children are more affected than adults, and risk factors include low socio-economic status, crowding, malnutrition, and humidity [2]. Skin NTDs may lead to reduced quality of life and affect psychological wellbeing because of the appearance, functional impairment, discrimination and stigmatisation of the individuals’ experience [3]. Residence in rural areas constitutes a population at risk for many cutaneous NTDs, including leprosy [4], Buruli ulcer [5], yaws [6], and scabies [7]. Scabies, caused by the Sarcoptes scabiei mite, affects an estimated 455 million people worldwide each year [2].

In many areas of Africa south of the Sahara where skin NTDs are endemic, there are few dermatologists, which reduces the prospects of effective diagnosis of these conditions which are mostly communicable [8]. Educational interventions are known to facilitate early detection of stigmatising or contagious diseases such as leprosy, and to prevent their spread in the community [9]. Community-based studies can also support development of new knowledge around integrated approaches to screening and mass management of certain endemic diseases [10].

The aim of this study was to determine the prevalence of skin NTDs in two schools and one rural community setting, that of village of Ndjéi, in rural north-east Togo. These findings can be used to provide reliable data that can inform local, national and international decision-making around skin NTD management.

Methods

Ethics statement

This study was approved by the Togo Bioethics Committee for Health Research (S2 Supplementary, reference: 012/2021/CBRS of 5 May 2021), and also by the University of Southampton ethics committee (S3 Supplementary, reference ERGO 63498). Written informed consent from participating adults was obtained. For minors, including adolescents, written informed consent were signed by a parent or adult competent guardian after an explanation in a language they understood (French or other local language).

This manuscript is also translated into French (S1 Supplementary). For this cross-sectional study, mobile clinics were set up by dermatologists in Togo, in school and community sites (Fig 1).

Fig 1. Location of Lomé, capital city of Togo and where the schools were sited, and the rural community of Ndjei.

Fig 1

Image drawn within our research group, the Clinical Informatics Research Unit at University of Southampton.

The primary schools are based in the Maritime region, located in the urban western and northern areas approximately ten kilometres from the centre of the capital city of Lomé.

The village of Ndjéi, with a population of about 3,000, is located in the Canton of Sirka, in the Kara region, about 400 km north of the capital, Lomé. The nearest large town is Atakpamé, approximately 160km away. Medicines were provided free of charge to participants (see S2 Supplementary). Where necessary, individuals were referred to the appropriate service in the healthcare system. For example, leprosy patients were referred to specific leprosy care centers at the district hospital. Both male and female dermatologists were available across school and community settings.

School environment

The consultations were conducted over three days in June 2021 in the schools of Afiadegnigban and Kpédevikopé. The participants were examined in a private room by one dermatologist, with a second examining dermatologist if required (e.g. to confirm a diagnosis). Each of the five dermatologists had a minimum of five years of experience in dermatological medical practice. The skin examination took approximately ten minutes, (with approved Covid 19 precautions). The dermatology team were assisted by two nurses and four community health workers at each site.

Community environment

The prefectural director of health informed the medical staff of the Ndjéi health centre (nurses, community health workers) that a team of dermatologists would be visiting from 25 to 29 October for mobile consultations. The village chief then informed the population. The population of Ndjéi is estimated at 3,000 people. The study team estimated that they would be able to see approximately one-third of the population during the study. The main activity of the population of Ndjéi is agricultural. A dermatologist attended the primary school to systematically examine all children and their parents/guardians. Another dermatologist carried out similar activity at the secondary school in Ndjéi. The village health centre was used as a consultation site where two dermatologists examined all people who attended for vaccination (national vaccination programme, Covid-19) or any other consultation (malaria, gastro-enteritis).

The study team set up a temporary clinic 3 km from the health centre, in a church. Households were randomly invited to come to the temporary clinic for a skin examination. Household selection was via the random walk method, with guidance from local health service colleagues (for example whether to purposively exclude a household). Of 25 selected households, 19 (76%) agreed to participate in the study. Participants had not previously been examined at other sites. The teams adhered to infection control guidance in relation to COVID-19.

Sample sizes

Given an estimated 392 and 390 number of students in each school, 3% margin of error, 95% confidence levels, we calculated a required sample size of 287 (3% margin of error, 95% confidence). For the community, given an estimated 3000 population we calculated a required sample size of 788 (3% margin of error, 95% confidence)

Diagnosis of skin NTDs

The following were considered to be cutaneous NTDs: the dermatoses on the WHO list (https://www.who.int/neglected_diseases/skin-ntds/en/) These were: Buruli ulcer; cutaneous leishmaniasis; post-kala-azar cutaneous leishmaniasis; leprosy; lymphatic filariasis (lymphoedema and hydrocele); mycetoma; onchocerciasis; scabies; yaws; and subcutaneous fungal infections. The study team also recorded the presence of superficial fungal diseases (for example, ringworm). The diagnosis of cutaneous NTDs was exclusively clinical, thus Buruli ulcer and yaws are suspected cases.

Data collection and analysis

Data were collected using a standardised form for each participant (S3 and S4 Supplementary files). Data collected included socio-demographic information (age, sex, level of education, number of people per household), clinical data (functional signs, type of lesions, site of lesions), diagnosis and questions on stigmatisation. Stigma was noted if the individual reported experiencing disapproval or prejudice because of their skin problem. The question on the data collection form was “If a skin infection is diagnosed, did the study participant experience stigma as a result of their infection?” (S4 Supplementary). The dermatologist asked if the individual was being treated differently or unfairly as a result of their skin infection, a common approach to gain an indication around levels of stigma [11].

If scabies was diagnosed, further data were collected on the clinical presentation and morphology and site of lesions. The data were entered in EPIDATA software, French version 3.1. Descriptive analyses were performed using Ran version 3.3.2 and results were presented in graphs, tables, frequency and percentages. Quantitative variables were described by means (± standard deviation) and qualitative variables by frequencies and percentages.

Results

Skin examinations were carried out on a total of 1401 people. This included 954 (68.1%) in the community (Ndjéi). There, 296 (31%) participants were seen at the Ndjéi primary school, 220 (23.1%) at the secondary school, 351 (36.8%) at the village health center and 87 (9.1%) at the temporary clinic. In the Lomé school setting, 447 children (31.9%) were examined out of a total of 782 regularly-enrolled children (and so 57.2% of the school population were participants here).

The mean of the subjects was 10±2.6 years (range 5–17 years) in the school setting and 19±15 years (range 1–90 years) in the community setting. The sex ratio (M/F) was 0.9 in both settings. Cutaneous skin infections were diagnosed in 438 (31.3%) patients, of whom 355 (81%) were in community settings (Table 1).

Table 1. Skin NTDs and mycoses observed, N (%).

School environment (n = 447) Community environment (n = 954) Total (N = 1401)
Cutaneous NTDs
Yes 20 (4.5) 85 (8.9) 105 (7.5)
No 427 (95.6) 869 (91.1) 1296 (92.5)
Type of cutaneous NTDs
Buruli ulcer 0 (0) 1 (0.1) 1 (0.1)
Leprosy 1 (0.2) 1 (0.1) 2 (0.1)
Scabies 19 (4.3) 67 (7.0) 86 (6.1)
Yaw 0 (0) 16 (1.7) 16 (1.1)
Mycoses observed
Total fungal infections 63 (14.1) 270 (28.3) 333 (23.8)
    Tinea capitis 16 (3.6) 108 (11.3) 124 (8.9)
    Pityriasis versicolor 44 (9.8) 156 (16.4) 200 (14.3)
    Tinea corporis 3 (0.7) 6 (0.6) 9 (0.6)
Total skin infections observed 83 (18.6) 355 (37.2) 438 (31.3)
Participants with no observed skin infections 364 (81.4) 599 (62.8) 963 (68.7)

There were 105 observed skin NTDs (7.5%). This included 20 in schools (4.5% of participants in that setting) and 85 (8.9%) in the rural community setting. When considered across all settings by age, there were 68 (6.7%) of NTDs in children, and 37 (9.7%) in adults.

There were 333 observed mycoses (23.8% across all sites). Within schools, there were 63 fungal infections (14.1%), and in the community, 270 fungal infections (28.3%). When considered across all settings by age, there were 259 (25.4%) fungal infections in children, and 74 (19.4%) in adults. There were two cases of leprosy, both being multibacillary (MB). One suspected case of Buruli Ulcer case was diagnosed, with late-stage presentation.

Of these participants, 14 (3.2%) had at least two skin infection at the same time. The most prevalent skin NTD was scabies, observed in 86 patients (6.1%) and suspected yaws in 16 participants (1.1%) (Table 1). The prevalence of scabies was 8.1% in adults compared to 5.4% in children; the prevalence of yaws similar across ages groups (1% in adults compared to 1.2% in children). Superficial fungal infection was more prevalent in children (25.4% in children compared to 19.4% in adults) (Table 2). In the school setting, five (6%) children with cutaneous NTDs reported being stigmatised, and four of them had refused to go to school for one or more days because of this dermatosis. In Ndjei, 44 (4.6%) participants reported having experienced stigma and 41 (93.2%) of them missed at least one day of school or work.

Table 2. Skin NTDs and mycoses observed, differentiated between children and adults, N (%).

Children (<18 years) (n = 1020) Adults (≥18 years) (n = 381) Total (N = 1401)
Cutaneous NTDs
Yes 68 (6.7) 37 (9.7) 105 (7.5)
No 952 (93.3) 344 (90.3) 1296 (92.5)
Type of cutaneous NTDs
Buruli ulcer 0 (0) 1 (0.3) 1 (0.1)
Leposy 1 (0.1) 1 (0.3) 2 (0.1)
Scabies 55 (5.4) 31 (8.1) 86 (6.1)
Yaw 12 (1.2) 4 (1) 16 (1.1)
Mycoses observed
Total fungal infections 259 (25.4) 74 (19.4) 333 (23.8)
    Tinea capitis 122 (11.9) 2 (0.5) 124 (8.9)
    Pityriasis versicolor 133 (13) 67 (17.6) 200 (14.3)
    Tinea corporis 4 (0.4) 5 (1.3) 9 (0.6)
Total skin infections observed 327 (32.1) 111 (29.1) 438 (31.3)
Participants with no observed skin infections 693 (67.9) 270 (70.9) 963 (68.7)

The mean age of scabies patients in the school setting was 10±2 years (range 5 and 13 years) and 20±14 years (range 1 and 72 years) in Ndjei. Across all reported NTDs, pruritus was the main symptom in all participants. Pruritus was more marked at night in 77 participants with scabies (89.5%), and 78 (90.7%) reported concurrent itching in household members. The main lesions noted were papules (77 patients; 89.5%), scratch lesions (74 patients; 86.0%), erosions/ulcerations (39 patients; 45.3%) and scabetic nodules (31 patients; 36%) (Table 3 and S5 Supplementary). These lesions were mainly located on the buttocks (68 cases; 79.1%), wrists (65; 75.6%), and interdigital spaces (56; 65.1%). The lesions were impetiginised in 36 patients and eczematised in 12 others. There were 36 participants (41.9%) who reported being stigmatised because of their scabies infection and 11 of them (30.6%) missed at least one day of school or work because of this stigma.

Table 3. Elementary lesions and lesion sites in scabies patients, N (%).

School environment (n = 19) Community environment (n = 67) Total (N = 86)
Age (years) 10±2.6 19±14 -
Sex
Male 10 (52.6) 29 (43.3) 39(45.3)
Female 9 (47.4) 38 (56.7) 47 (56.3)
Morphology of lesions
Papules 11 (57.9) 66 (98.5) 77 (89.5)
Scratch lesions 14 (73.7) 60 (89.6) 74 (86)
Erosions/Ulcerations 13 (68.4) 26 (38.8) 39 (45.3)
Scabious nodules 10 (52.6) 21 (31.3) 31 (36)
Vesicles/bubbles 6 (32.6) 11 (16.4) 17 (19.8)
Pustules 9 (47.4) 3 (4.5) 12 (14)
Burrows 3 (15.8) 2 (3) 5 (5.8)
Other lesions 0 (0.0) 3 (4.5) 3 (3.5)
Site of lesions
Buttocks 14 (73.7) 54 (80.6) 68 (79.1)
Wrists 13 (68.4) 52 (77.6) 65 (75.6)
Interdigital spaces 14 (73.7) 42 (62.7) 56 (65.1)
Breasts 6 (31.6) 27 (40.3) 33 (38.4)
Forearms 5 (26.3) 26 (38.8) 31 (36)
Arms 2 (10.5) 24 (35.8) 26 (30.2)
Thighs 0(0) 21 (31.3) 21 (24.4)
External genitalia 4 (21.1) 15 (22.4) 19 (22.1)
Peri-umbilical region 2 (10.5) 15 (22.4) 17 (19.8)
Palms of the hands 0 (0) 5 (7.5) 5 (5.8)
Feet 0 (0) 3(4.5) 3 (3.5)
Other 4 (21.1) 9 (13.4) 13 (15.1)
Complications
Impetiginization 3 (15.8) 33 (49.3) 36 (41.9)
Eczematization 2 (10.5) 10 (15) 12 (14)
Stigma
Received stigma?
And of those who answered yes to stigma—Missing school or work?
3 (15.8)
2 (66.7)
33 (49.3)
9 (27.3)
36 (41.9)
11 (30.6)

Discussion

This study has provided evidence of the prevalence of skin NTDs and fungal infections in school and community-based settings in Togo. There is a very high prevalence of superficial mycoses, with scabies and yaws being the most common skin NTDs.

The prevalence of skin NTDs vary greatly by setting type (for example community, or institution) and by country. In our study, the prevalence of cutaneous NTDs was 7.5%, less than the 17.2% from an Ethiopian hospital study [12]. Many other studies have focused on a single, or small number of, NTDs, yet most of these diseases share some of the same risk factors, can be found concurrently in the same patient, and could arguably be more efficiently investigated together [1]. Here, 3.2% of participants had two cutaneous NTDs at the same time. An Ivorian study also reported the frequent association of patients reporting multiple cutaneous conditions, particularly fungal infections alongside one case of leprosy [13]. The recommendations of the WHO NTDs Roadmap indicate that these conditions should be considered alongside each other rather than separately [1].

Fungal diseases (23.8%) were the most prevalent skin infection in our study, followed by scabies (6.1%) and yaws (1.1%). The WHO list of cutaneous NTDs previously referred to ‘fungal infections’ [14]. However, a more pragmatic definition of skin NTDs typically refers to deep tissue or subcutaneous mycoses, such as mycetoma, rather than also including the superficial fungal diseases like ringworm. A study in Ethiopia found a fungal infection prevalence of 21.1% [12], a level that is similar to our findings. A study in Benin reported a higher prevalence for fungal dermatoses of 49% [15].

The clinical diagnosis of yaws was made in 16 patients in the village of Ndjei, while no cases were found in schools in the urban environment of Lomé. The diagnosis of yaws in this study was clinical, and its possible that prevalence may be overestimated due to lack of confirmation by diagnostic tests. The skin presentation of primary yaws can be similar to cutaneous leishmaniasis or mycobacterial disease [16]. In a similar study in Côte d’Ivoire, of 15 cases of clinically suspected yaws, the diagnosis was confirmed in only 8 individuals [13].

The prevalence of scabies in schools (4.3%) is similar to the prevalence in studies of schoolchildren in Egypt, Nigeria and Turkey (4.4%, 4.8% and 2.16% respectively) [1719]. In contrast, a higher prevalence of 39.4% and 17.2% was observed in schoolchildren in India and Cameroon respectively [20,21]. The community prevalence of scabies in this study is higher than in the school setting, but similar to the 6% reported in a Tanzanian rural community [22], and higher than the 2.8% reported in a Cameroonian study [23]. Where community prevalence is high, this increases the risks of scabies outbreaks within the school setting, for example a Ghana study highlighted overcrowded classrooms and sharing of sleeping mats as a likely factor contributing to an outbreak of 92 cases in one school [24].

Pruritus was the main symptom of scabies in our participants, as also reported elsewhere [24,25]. Pruritus, especially nocturnal pruritus and pruritus in families, is typically one of the most suggestive feature of scabies [2]. The buttocks, wrists and interdigital spaces were here observed as the main sites of scabies lesions. These are common sites for a scabies infection to present, though clinical appearance can occur on almost any part of the body, and the presentation may be subtle. This can make diagnosis difficult, with the presentation being under clothing or not reported by the patient, or missed by the healthcare worker. Better knowledge around the most-commonly affected body sites can support simple training methods that aid diagnosis [26].

Bacterial infection (41.9% of cases) was the main complication of scabies in our study. The frequent use of traditional remedies to treat dermatoses could also promote bacterial infection or eczematisation of lesions [27]. Where the pruritus is difficult to conceal, this may be stigmatizing or lead to social exclusion. In an Ethiopian study, almost one third of scabies patients reported stigma [7]. In our study and across all NTDs, 49 people reported having experienced stigma. This stigmatisation and the problem of absenteeism associated with it should encourage the health authorities to make the treatment of cutaneous NTDs free of charge, including consultation fees, and provision of anti-cutaneous NTD drugs. This can help to persuade the population to seek a consultation.

The evidence base around diagnosis, management and identification of skin NTDs is variable, and prevalence data can be inconclusive or out of date. Studies on scabies may more commonly focus on outbreaks or take place in institutional settings [24,28]. This is in part due to higher burdens of disease having been observed, but also due to their relatively simplicity compared with large community surveys. A Liberia study focused on scabies in the community, reporting a prevalence of 9.3% [29], similar to the 7.2% scabies community prevalence observed here.

In 2022, the WHO have revised an NTD roadmap [1], with targets around clear reductions and eliminations of some NTDs by 2030, and a section focused on their epidemiology and prevalence. Much of this global ambition is reliant on donations of medicines such as ivermectin, and for them to be incorporated into Mass Drug Administrations (MDA)s. It is likely that MDAs will have the most impact in higher-burden areas, and thus the data on the community prevalence is vital. In lower burden settings, the WHO report that surveillance and facility-based care may be more appropriate[1].

There are few data on institutional or community prevalence of NTDs in Togo. The country has had significant successes with control programmes, having eliminated dracunculiasis (2011), lymphatic filariasis (2017), and human African trypanosomiasis (2020). The data from this study shows skin NTDs such as scabies and fungal dermatoses are highly-prevalent and may be harder to eliminate. Scabies may be controlled with mass drug administration of ivermectin (which is also used to control onchocerciasis). The WHO are developing provisional guidance to around the mass use of ivermectin for scabies control [30].

The main limitations of our study are around the selection of the study population. Within schools, there was reluctance from some parents/guardians to give written consent to allow their children to participate which explains why only 57.2% of the students were examined in the school setting. If children with a skin infection are indeed being stigmatized, then they may have been more likely to be absent at the time of our study, and thus prevalence may be underestimated. Similarly in the rural community, some participant were attending a vaccination clinic at the health centre. Thus, the characteristics of children absent from school and those who did not attend in Ndjei may bias the results. The sample analysed here may not be representative of these populations as a whole. With school and community health programs such as mass drug administrations or vaccine rollouts, uptake is typically higher where there has been extensive community engagement [31]. A sustained programme of health promotion, across school and community settings, may encourage a proactive approach to healthcare-seeking behaviour, plus participation in research studies. Diagnoses were clinical, and no further diagnostics were performed, thus diagnoses of yaws and Buruli ulcer are suspected rather than confirmed.

Conclusion

Our study shows that the burden of cutaneous NTDs and fungal infections is high in school and community settings in Togo. Scabies was the most prevalent infection. An integrated management approach as well as mass drug administration programmes may be effective in controlling of these NTDs. However, there should also be consideration around approaches to reduce associated stigma, with improved health promotion and education across institutional and community settings that encourage early reporting to a health facility.

Supporting information

S1 Supplementary. French language version of this manuscript.

(DOCX)

S2 Supplementary. List of medicines available during the study.

(DOCX)

S3 Supplementary. Data collection form used in this study, French version.

(DOCX)

S4 Supplementary. Data collection form used in this study, English version.

(DOCX)

S5 Supplementary. Further presentation and vizualisation of scabies data.

(DOCX)

Acknowledgments

We thank the administrative and health authorities of the Golfe and Binah health districts for allowing us to carry out this study. Thanks to Ashley Heinson, University of Southampton, for his efforts in developing the heat map visualisations of scabies presentations on different body sites. We would like to pay tribute to Dr Mwelecele Ntuli Malecela who died in 2022 and was Director of the WHO Department of Control of Neglected Tropical Diseases; may she rest in peace.

Data Availability

An anonymized dataset can be downloaded from https://doi.org/10.6084/m9.figshare.21276693.v1.

Funding Statement

The project received a Business Development Grant from the University of Southampton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organisation. Ending the Neglect to Attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030. Geneva, 2020 https://www.who.int/neglected_diseases/Ending-the-neglect-to-attain-the-SDGs—NTD-Roadmap.pdf (accessed July 28, 2021).
  • 2.Engelman D, Cantey PT, Marks M, et al. The public health control of scabies: priorities for research and action. Lancet (London, England) 2019; 394: 81–92. doi: 10.1016/S0140-6736(19)31136-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Weiss MG. Stigma and the Social Burden of Neglected Tropical Diseases. PLoS Negl Trop Dis 2008; 2: e237. doi: 10.1371/journal.pntd.0000237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Suzuki K, Akama T, Kawashima A, Yoshihara A, Yotsu RR, Ishii N. Current status of leprosy: epidemiology, basic science and clinical perspectives. J Dermatol 2012; 39: 121–9. doi: 10.1111/j.1346-8138.2011.01370.x [DOI] [PubMed] [Google Scholar]
  • 5.Yotsu RR, Murase C, Sugawara M, et al. Revisiting Buruli ulcer. J Dermatol 2015; 42: 1033–41. doi: 10.1111/1346-8138.13049 [DOI] [PubMed] [Google Scholar]
  • 6.Kazadi WM, Asiedu KB, Agana N, Mitjà O. Epidemiology of yaws: an update. Clin Epidemiol 2014; 6: 119–28. doi: 10.2147/CLEP.S44553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dagne H, Dessie A, Destaw B, Yallew WW, Gizaw Z. Prevalence and associated factors of scabies among schoolchildren in Dabat district, northwest Ethiopia, 2018. Environ Health Prev Med 2019; 24: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mitjà O, Marks M, Bertran L, et al. Integrated Control and Management of Neglected Tropical Skin Diseases. PLoS Negl Trop Dis 2017; 11: e0005136. doi: 10.1371/journal.pntd.0005136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Barreto JG, Guimarães L de S, Frade MAC, Rosa PS, Salgado CG. High rates of undiagnosed leprosy and subclinical infection amongst school children in the Amazon Region. Mem Inst Oswaldo Cruz 2012; 107 Suppl 1: 60–7. doi: 10.1590/s0074-02762012000900011 [DOI] [PubMed] [Google Scholar]
  • 10.Engelman D, Fuller LC, Solomon AW, et al. Opportunities for Integrated Control of Neglected Tropical Diseases That Affect the Skin. Trends Parasitol 2016; 32: 843–54. doi: 10.1016/j.pt.2016.08.005 [DOI] [PubMed] [Google Scholar]
  • 11.Luck-Sikorski C, Roßmann P, Topp J, Augustin M, Sommer R, Weinberger NA. Assessment of stigma related to visible skin diseases: a systematic review and evaluation of patient-reported outcome measures. J Eur Acad Dermatology Venereol 2022; 36: 499–525. [DOI] [PubMed] [Google Scholar]
  • 12.Abdela SG, Diro E, Zewdu FT, et al. Looking for NTDs in the skin; an entry door for offering patient centered holistic care. J Infect Dev Ctries 2020; 14: 16S–21S. doi: 10.3855/jidc.11707 [DOI] [PubMed] [Google Scholar]
  • 13.Yotsu RR, Kouadio K, Vagamon B, et al. Skin disease prevalence study in schoolchildren in rural Côte d’Ivoire: Implications for integration of neglected skin diseases (skin NTDs). PLoS Negl Trop Dis 2018; 12: e0006489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.World Health Organization. Archived webpage World Health Organization NTDs. 2020. https://web.archive.org/web/20200714092426/https://www.who.int/neglected_diseases/skin-ntds/en/ (accessed July 21, 2022). [Google Scholar]
  • 15.Barogui YT, Diez G, Anagonou E, et al. Integrated approach in the control and management of skin neglected tropical diseases in Lalo, Benin. PLoS Negl Trop Dis 2018; 12: e0006584. doi: 10.1371/journal.pntd.0006584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mitjà O, Hays R, Lelngei F, et al. Challenges in Recognition and Diagnosis of Yaws in Children in Papua New Guinea. Am J Trop Med Hyg 2011; 85: 113. doi: 10.4269/ajtmh.2011.11-0062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Inanir I, Turhan Şahin M, Gündüz K, Dinç G, Türel A, Serap Öztürkcan D. Prevalence of skin conditions in primary school children in Turkey: differences based on socioeconomic factors. Pediatr Dermatol 2002; 19: 307–11. doi: 10.1046/j.1525-1470.2002.00087.x [DOI] [PubMed] [Google Scholar]
  • 18.Salah Hegab D, Mahfouz Kato A, Ali Kabbash I, Maged Dabish G. Scabies among primary schoolchildren in Egypt: sociomedical environmental study in Kafr El-Sheikh administrative area. Clin Cosmet Investig Dermatol 2015; 8: 105. doi: 10.2147/CCID.S78287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ogunbiyi AO, Owoaje E, Ndahi A. Prevalence of skin disorders in school children in Ibadan, Nigeria. Pediatr Dermatol 2005; 22: 6–10. doi: 10.1111/j.1525-1470.2005.22101.x [DOI] [PubMed] [Google Scholar]
  • 20.Sarkar M. Personal hygiene among primary school children living in a slum of Kolkata, India. J Prev Med Hyg 2013; 54: 153–8. [PMC free article] [PubMed] [Google Scholar]
  • 21.Kouotou EA, Nansseu JRN, Kouawa MK, Zoung-Kanyi Bissek AC. Prevalence and drivers of human scabies among children and adolescents living and studying in Cameroonian boarding schools. Parasites and Vectors 2016; 9: 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Henderson CA. Skin disease in rural Tanzania. Int J Dermatol 1996; 35: 640–2. doi: 10.1111/j.1365-4362.1996.tb03688.x [DOI] [PubMed] [Google Scholar]
  • 23.Bissek ACZ, Tabah EN, Kouotou E, et al. The spectrum of skin diseases in a rural setting in Cameroon (sub-Saharan Africa). BMC Dermatol 2012; 12. doi: 10.1186/1471-5945-12-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kaburi BB, Ameme DK, Adu-Asumah G, et al. Outbreak of scabies among preschool children, Accra, Ghana, 2017. BMC Public Health 2019; 19: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sanei-Dehkordi A, Soleimani-Ahmadi M, Zare M, Jaberhashemi SA. Risk factors associated with scabies infestation among primary schoolchildren in a low socio-economic area in southeast of Iran. BMC Pediatr 2021; 21. doi: 10.1186/S12887-021-02721-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Osti MH, Sokana Oliver, Lake S, et al. The body distribution of scabies skin lesions. JEADV Clin Pract 2022; 1: 111–21. [Google Scholar]
  • 27.Kobangué L, Guéréndo P, Abéyé J, Namdito P, Mballa MD, Gresenguet G. [Scabies: epidemiological, clinical and therapeutic features in Bangui]. Bull Soc Pathol Exot 2014; 107: 10–4. [DOI] [PubMed] [Google Scholar]
  • 28.Cassell JA, Middleton J, Nalabanda A, et al. Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis 2018; 18: 894–902. doi: 10.1016/S1473-3099(18)30347-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Collinson S, Timothy J, Zayzay SK, et al. The prevalence of scabies in Monrovia, Liberia: A population-based survey. PLoS Negl Trop Dis 2020; 14: e0008943–e0008943. doi: 10.1371/journal.pntd.0008943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.World Health Organization. Informal consultation on a framework for scabies control. 2019. https://www.who.int/publications/i/item/9789240008069 (accessed July 21, 2022). [Google Scholar]
  • 31.Manyeh A, Ibisomi L, R R, Baiden F, Chirwa T. Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana. PLoS Negl Trop Dis 2020; 15: e0009341. doi: 10.1371/journal.pntd.0007009 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010697.r001

Decision Letter 0

Dileepa Senajith Ediriweera, Paul J Converse

25 Sep 2022

Dear Dr Head,

Thank you very much for submitting your manuscript "Prevalence of skin Neglected Tropical Diseases and superficial fungal infections in two peri-urban schools and one rural community setting in Togo" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Paul J. Converse

Academic Editor

PLOS Neglected Tropical Diseases

Dileepa Ediriweera

Section Editor

PLOS Neglected Tropical Diseases

***********************

Dear Dr. Head,

Your manuscript has been reviewed by three experts in the field and also by myself. The data and results are an interesting summary of convenience samples that may lead to more thorough future studies. Please carefully and fully respond to all of the reviewers' comments to help make the manuscript acceptable for publication. Please also carefully review the text and tables for missing words, and grammatical and spelling errors. Thank you for your submission to PLoS NTD.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: This cannot really be called a prevalence study as almost 40% of the school children invited did not attend because of lack of parental consent and from later figures only 1/3 of the community population was investigated. It is not clear therefore whether attendees were truly respresentative of the whole population

So without understanding whether those who did not attend had the same rate and distribution of skin disease and Skin NTDs we do not have a true picture of prevalence. The authors briefly discuss this at the end in relation to the school population.

I note that medicines were provided free of charge – was this for the common skin diseases ?

“Where necessary, individuals were referred to the appropriate service in the

healthcare system” . Is this in reference to NTDs such as leprosy ?

What were the other skin infections ( briefly) ?

How was the issue of stigma approached – for instance what questions were asked ? This is critical to understanding the implications of this work and more detail is needed. I presume it is this one from the supplementary material Si «oui» à la question sur la stigmatisation, le participant à l’étude n’a-t-il pas assisté à un ou plusieurs jours de travail ou d’école en raison de la stigmatisation?. There should be a comment in the text – but is this sufficient evidence to indicate stigmatisation ?

Reviewer #3: Hypothesis is clearly stated, and the study design is appropriate to investigate the stated objective. Please clarify the "community setting" (line 22-25) in the introduction.

Given that more than 50% of the population in the rural setting were school children, it would be good to add subset analysis of school children vs non school children in the rural setting, etc.

Please explain how the choice of schools and the village was random.

No concerns about ethical or regulatory requirements.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: Page 14 scabies furrows - ? Burrows.

This sentence is a bit confusing – “These fungal diseases are not always considered as neglected

diseases, but they have previously been referred to in the WHO list of cutaneous NTDs”.

Superficial fungal infections are not listed by WHO as Skin NTDS. The issue here is that if skin examination is used as an entry point for NTD detection, for instance as in the new Framework programme published this year, it is a pragmatic and practical approach to include the common prevalent skin diseases such as superficial mycoses when dispensing treatment rather than to ignore them. So they are included in, for instance, the WHO App and training manual but are not listed as NTDs

Reviewer #3: The analysis of the data, especially the given percentages are not clear and partly faulty. Please correct. State clearly what the denominator is.

Line 34 the percentages in parentheses behind the numbers are incorrect instead of 6.7% it should for example be 4.4%

In the text it is described, that 14 patients had more than 1 skin infection, this is not reflected in table 1 and table 2 the number of skin infections plus the number of patients without a skin infections adds up to 100%, if there were 14 patients with more than 1 skin infection, there would need to be at least 14 skin infections more, or the number of patients without a skin infection would need to be higher.

Table 3 last row, the percentages don't fit. Please recheck all percentages and make clear the percentage of what (sub)population it is

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: In discussing the accuracy of the diagnosis of yaws can you provide an example of a disease that might be confused with yaws ?

The authors point out the main limitation of this study which is the comparatively low participation rate in schools . Without examining non attenders it is not possible to comment on the accuracy of the prevalence figures although these may not have been affected. But it would be helpful to explore and suggest ways of increasing participation for the future as this is critical information for the success of Skin NTD programmes.

Reviewer #3: Please add in the discussion a part discussing other possibilities/more in depth how the low percentage of school children could have been effected by the fact, that people with skin NTD rather stay at home, among other theories maybe.

Add, that in the rural setting a subset was investigated, because these were people, who were already coming to the health center, this is a subset of the population, which could differ from the overall population.

Line 258 - add percentage of people reported stigma/all people with NTDs

Line 287 - please reiterate further on the limitations of the study, e.g. on the small sample size

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: Consider using a map, which shows also other cities in Togo, to show where the remote community (Ndjéi) is.

Line 69 - add how climate and rainfall are risk factors and what climate is a risk factor.

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: Line 77 - not all of the skin NTDs are communicable (for example BU is likely from the environment as are most of the fungal diseases) and it is not clear that it is the absence of dermatologists that creates a barrier to their control.

Line 79- the reference appears to be about leprosy; I am not aware of any good evidence that increased access to dermatologists (which is undoubtedly a good thing) helps break chains of transmission of yaws or scabies. Please reword.

Methods - were dermatologists of both genders available?

- What if any attempts were made to standardise the performance of the dermatologists and the terminology they used?

How was the random selection of households done? Simple random sampling? Random walk? Where was the randomisation list generated from.

It is not possible to make a clinical diagnosis of yaws reliably - this has been shown in numerous papers. Similarly BU can not be diagnosed reliably solely on clinical grounds. I would suggest you reword the methods to make clear that a suspected diagnosis could be made but not an actual one. Tables and references to these diagnoses in the results and discussion also need to be amended.

- In addition for yaws it is critical to differentiate between papillomas (specific, likely to be yaws) and ulcers (non specific, most commonly wont be yaws)

How were the questions on stigma asked/collected? Is this a validated tool.

The information on consent is provided twice in duplicate (line 101 and then again in the ethics section) please remove one of these.

Results - what is a furrow - I presume this is a typo and is meant to be burrow.

Discussion - I do not think you should be referring to a diagnosis of yaws here and certianly not claiming it was common without a) some details on papillomas vs ulcers and b) given the complete absence of diagnostic testing

Line 225 I am not aware that WHO has ever regarded superficial mycoses as NTDs and the reference you provide for this statmeent (13) does not suggest this either. Please remove/reword this.

The discussion is quite long (>1200 words) and I would suggest benefit from editing to make it more concise.

Where are data available from - please provide this informaiton

Reviewer #2: While I recognise the difficulty of carrying out studies of this nature some attempt should be made to show that the population examined were representative of the whole

Reviewer #3: Good study overall, which gives insight into an understudied topic and adds value to the community, adding important information regarding the prevalence of skin NTDs in another african country. The study is limited to a low number of participants and the methods used are subjective. Not sufficient information about the training of the doctors is given, and as clinical diagnoses were the only method to diagnose a high false positive/negative rate must be assumed. The relevance of the sub-analysis is questionable as no major conclusions were found. Research and publication ethics seem to have been respected. A good study requiring some more work on the analysis part.

Data for the socio-demographic information collected lacks.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010697.r003

Decision Letter 1

Dileepa Senajith Ediriweera, Paul J Converse

7 Dec 2022

Dear Dr Head,

We are pleased to inform you that your manuscript 'Prevalence of skin Neglected Tropical Diseases and superficial fungal infections in two peri-urban schools and one rural community setting in Togo' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Paul J. Converse

Academic Editor

PLOS Neglected Tropical Diseases

Dileepa Ediriweera

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

Dear Dr. Head and colleagues,

Congratulations on the acceptance of your manuscript for publication in PLoS NTD. At your discretion, you may wish to attend to the comments of Reviewer 3 before the paper goes to press. The suggestions should help clarify your message for all readers.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: The authors have addressed my concerns

Reviewer #3: Please explained the paragraph "Sample Size", what is meant with required in this context? Required for what purpose?

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: The authors have addressed my concerns

Reviewer #3: Tables are better now.

The results part would profit from having the percentages explained in the text instead of behind the numbers. E.g. line 185 instead of "There were 105 observed skin NTDs (7.5%)." Write "In 7.5% of the examined study population NTDs were observed" etc.

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: The authors have addressed my concerns

Reviewer #3: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: The authors have addressed my concerns

Reviewer #3: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: I am satisifed appropriate changes have been made

Reviewer #2: The authors have addressed my concerns

Reviewer #3: The quality and usability of the provided data set could be improved if the abbreviations used in the data set would be explained.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Oliver Komm

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010697.r004

Acceptance letter

Dileepa Senajith Ediriweera, Paul J Converse

14 Dec 2022

Dear Dr Head,

We are delighted to inform you that your manuscript, "Prevalence of skin Neglected Tropical Diseases and superficial fungal infections in two peri-urban schools and one rural community setting in Togo," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Supplementary. French language version of this manuscript.

    (DOCX)

    S2 Supplementary. List of medicines available during the study.

    (DOCX)

    S3 Supplementary. Data collection form used in this study, French version.

    (DOCX)

    S4 Supplementary. Data collection form used in this study, English version.

    (DOCX)

    S5 Supplementary. Further presentation and vizualisation of scabies data.

    (DOCX)

    Attachment

    Submitted filename: author response to reviewers v2.docx

    Data Availability Statement

    An anonymized dataset can be downloaded from https://doi.org/10.6084/m9.figshare.21276693.v1.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES